WHO slams US-funded newborn vaccine trial as "unethical"
WHO slams US-funded newborn vaccine trial as "unethical" is drawing significant interest across the industry.
CDC awarded $1.6 million for study birth dose of hepatitis B vaccine in Guinea-Bissau.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- 130-acre startup & innovation hub to come up in Wadala
- Empowering Innovation: NXP India's Tech Startup Challenge Season 6
- Top Startup and Tech Funding News - February 23, 2025
- Uttarakhand CM flags off CSR-funded vehicles to boost health and education services in Champawat
Source: Original →